HUTCHMED (China) Limited (HCM)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

281.00p
   
  • Change Today:
    -3.00p
  • 52 Week High: 352.00p
  • 52 Week Low: 192.40p
  • Currency: UK Pounds
  • Shares Issued: 871.56m
  • Volume: 30,671
  • Market Cap: £2,449.09m
  • RiskGrade: 226
  • Beta: 1.20

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
87.23% above the market average87.23% above the market average87.23% above the market average87.23% above the market average87.23% above the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
75.4% below the market average75.4% below the market average75.4% below the market average75.4% below the market average75.4% below the market average
30.23% below the sector average30.23% below the sector average30.23% below the sector average30.23% below the sector average30.23% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
74.03% below the market average74.03% below the market average74.03% below the market average74.03% below the market average74.03% below the market average
52% below the sector average52% below the sector average52% below the sector average52% below the sector average52% below the sector average
Price Chg 3m
53.31% above the market average53.31% above the market average53.31% above the market average53.31% above the market average53.31% above the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
54.24% below the market average54.24% below the market average54.24% below the market average54.24% below the market average54.24% below the market average
69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average
Momentum 20
82.89% below the market average82.89% below the market average82.89% below the market average82.89% below the market average82.89% below the market average
82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
24.35% below the market average24.35% below the market average24.35% below the market average24.35% below the market average24.35% below the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
ROCE
65.32% below the market average65.32% below the market average65.32% below the market average65.32% below the market average65.32% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
41.66% above the market average41.66% above the market average41.66% above the market average41.66% above the market average41.66% above the market average
75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
65.29% above the market average65.29% above the market average65.29% above the market average65.29% above the market average65.29% above the market average
72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average
Operating Profit Loss
35.68% above the market average35.68% above the market average35.68% above the market average35.68% above the market average35.68% above the market average
83.67% above the sector average83.67% above the sector average83.67% above the sector average83.67% above the sector average83.67% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
77.43% above the market average77.43% above the market average77.43% above the market average77.43% above the market average77.43% above the market average
82.98% above the sector average82.98% above the sector average82.98% above the sector average82.98% above the sector average82.98% above the sector average
Cash
79.69% above the market average79.69% above the market average79.69% above the market average79.69% above the market average79.69% above the market average
87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HCM Market Data

Currency UK Pounds
Share Price 281.00p
Change Today -3.00p
% Change -1.06 %
52 Week High 352.00p
52 Week Low 192.40p
Volume 30,671
Shares Issued 871.56m
Market Cap £2,449.09m
Beta 1.20
RiskGrade 226

HCM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
73.27% below the market average73.27% below the market average73.27% below the market average73.27% below the market average73.27% below the market average
32% below the sector average32% below the sector average32% below the sector average32% below the sector average32% below the sector average
Price Trend
16.39% above the market average16.39% above the market average16.39% above the market average16.39% above the market average16.39% above the market average
63.27% above the sector average63.27% above the sector average63.27% above the sector average63.27% above the sector average63.27% above the sector average
Income Not Available
Growth
71.12% above the market average71.12% above the market average71.12% above the market average71.12% above the market average71.12% above the market average
88.24% above the sector average88.24% above the sector average88.24% above the sector average88.24% above the sector average88.24% above the sector average

HCM Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:15 175 @ 281.88p
16:12 154 @ 281.00p
16:12 125 @ 281.00p
16:12 475 @ 281.00p
16:12 436 @ 281.00p

HCM Key Personnel

Chair Dan Eldar
CEO Weiguo Su

Top of Page